.png)
Urinary Tract Infection Treatment Market By Drug Type (Tetracycline, Azoles and Amphotericin B, Nitrofurans, Quinolones, Aminoglycoside antibiotics, Sulphonamides and Other Drug Types), Indication (Recurring Complicated UTI, Uncomplicated UTI and Complicated UTI) and Distribution Channel (Retail Pharmacies, Hospital Pharmacies and e-Pharmacies) - Global Industry Analysis And Forecast To 2027
Published On : September 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC091272
SEGMENTS & REGIONS:
- By Drug Type: Tetracycline, Azoles and Amphotericin B, Nitrofurans, Quinolones, Aminoglycoside antibiotics, Sulphonamides and Other Drug Types
- Indication: Recurring Complicated UTI, Uncomplicated UTI and Complicated UTI
- and Distribution Channel: Retail Pharmacies, Hospital Pharmacies and e-Pharmacies
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook
Urinary Tract Infection (UTI) is caused due to microbes, these microbes a so small that microscope is needed to detect them. It is a common infection seen in human beings. Major number of Urinary Tract Infection (UTI) is caused due to bacterium, some caused by fungus & in rare cases it is caused by virus. Urinary Tract is made up of organs like kidneys, bladders, ureters and urethra and Urinary Tract Infection (UTI) can be caused in any of this part. Upper tract UTIs are rare as compared to the lower tract UTIs, also the severity of infection is more. Increasing number of cases related to Urinary Tract Infection (UTI) is the reason the treatment demand has increased across the globe. Therefore, the Urinary Tract Infection Treatment Market is anticipated to expand and has tremendous scope during the forecast period. The global Urinary Tract Infection Treatment Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Urinary Tract Infection Treatment Market is based on segment, by Drug Type the market is segmented into Tetracycline, Azoles and Amphotericin B, Nitrofurans, Quinolones, Aminoglycoside antibiotics, Sulphonamides and Other Drug Types, by Indication the market is segmented into Recurring Complicated UTI, Uncomplicated UTI and Complicated UTI, and by Distribution Channel the market is segmented into Retail Pharmacies, Hospital Pharmacies and e-Pharmacies.
- Urinary Tract Infection Treatment Market, By Drug Type
- Tetracycline
- Azoles and Amphotericin B
- Nitrofurans
- Quinolones
- Aminoglycoside antibiotics
- Sulphonamides
- Other Drug Types
- Urinary Tract Infection Treatment Market, By Indication
- Recurring Complicated UTI
- Uncomplicated UTI
- Complicated UTI
- Urinary Tract Infection Treatment Market, By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- e-Pharmacies
Regional Insights
On a global front, the Urinary Tract Infection Treatment Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Urinary Tract Infection Treatment Market due to number of cases of catheter associated infections, neurogenic bladder infections & also more R&D related to the development of new drugs.
Urinary Tract Infection Treatment Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are F. Hoffmann-La Roche Ltd., Novartis AG, Roche Ltd., Cipla Ltd., Boehringer Ingelheim, Johnson & Johnson, GlaxoSmithKline, AstraZeneca Plc, Bayer AG and Pfizer Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Roche Ltd.
- Cipla Ltd.
- Boehringer Ingelheim
- Johnson & Johnson
- GlaxoSmithKline
- AstraZeneca Plc
- Bayer AG
- Pfizer Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Urinary Tract Infection Treatment Market, By Drug Type, Estimates and Forecast, 2017-2027 ($Million)
o Tetracycline
o Azoles and Amphotericin B
o Nitrofurans
o Quinolones
o Aminoglycoside antibiotics
o Sulphonamides
o Other Drug Types
o Urinary Tract Infection Treatment Market, By Indication, Estimates and Forecast, 2017-2027 ($Million)
o Recurring Complicated UTI
o Uncomplicated UTI
o Complicated UTI
o Urinary Tract Infection Treatment Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Retail Pharmacies
o Hospital Pharmacies
o e-Pharmacies
Urinary Tract Infection Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Urinary Tract Infection Treatment Market, By Country
o U.S. Urinary Tract Infection Treatment Market
o Canada Urinary Tract Infection Treatment Market
o Mexico Urinary Tract Infection Treatment Market
o Europe
§ Europe Urinary Tract Infection Treatment Market, By Country
o Germany Urinary Tract Infection Treatment Market
o UK Urinary Tract Infection Treatment Market
o France Urinary Tract Infection Treatment Market
o Russia Urinary Tract Infection Treatment Market
o Italy Urinary Tract Infection Treatment Market
o Rest of Europe Urinary Tract Infection Treatment Market
o Asia-Pacific
§ Asia-Pacific Urinary Tract Infection Treatment Market, By Country
o China Urinary Tract Infection Treatment Market
o Japan Urinary Tract Infection Treatment Market
o South Korea Urinary Tract Infection Treatment Market
o India Urinary Tract Infection Treatment Market
o Southeast Asia Urinary Tract Infection Treatment Market
o Rest of Asia-Pacific Urinary Tract Infection Treatment Market
o South America
§ South America Urinary Tract Infection Treatment Market, By Country
o Brazil Urinary Tract Infection Treatment Market
o Argentina Urinary Tract Infection Treatment Market
o Columbia Urinary Tract Infection Treatment Market
o Rest of South America Urinary Tract Infection Treatment Market
o Middle East and Africa
§ Middle East and Africa Urinary Tract Infection Treatment Market, By Country
o Saudi Arabia Urinary Tract Infection Treatment Market
o UAE Urinary Tract Infection Treatment Market
o Egypt Urinary Tract Infection Treatment Market
o Nigeria Urinary Tract Infection Treatment Market
o South Africa Urinary Tract Infection Treatment Market
o Rest of MEA Urinary Tract Infection Treatment Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Urinary Tract Infection Treatment Market, By Drug Type
5.1. Introduction
5.2. Global Urinary Tract Infection Treatment Revenue and Market Share by Drug Type (2017-2027)
5.2.1. Global Urinary Tract Infection Treatment Revenue and Revenue Share by Drug Type (2017-2027)
5.3. Tetracycline
5.3.1. Global Tetracycline Revenue and Growth Rate (2017-2027)
5.4. Azoles and Amphotericin B
5.4.1. Global Azoles and Amphotericin B Revenue and Growth Rate (2017-2027)
5.5. Nitrofurans
5.5.1. Global Nitrofurans Revenue and Growth Rate (2017-2027)
5.6. Quinolones
5.6.1. Global Quinolones Revenue and Growth Rate (2017-2027)
5.7. Aminoglycoside antibiotics
5.7.1. Global Aminoglycoside antibiotics Revenue and Growth Rate (2017-2027)
5.8. Sulphonamides
5.8.1. Global Sulphonamides Revenue and Growth Rate (2017-2027)
5.9. Other Drug Types
5.9.1. Global Other Drug Types Revenue and Growth Rate (2017-2027)
6. Urinary Tract Infection Treatment Market, By Indication
6.1. Introduction
6.2. Global Urinary Tract Infection Treatment Revenue and Market Share by Indication (2017-2027)
6.2.1. Global Urinary Tract Infection Treatment Revenue and Revenue Share by Indication (2017-2027)
6.3. Recurring Complicated UTI
6.3.1. Global Recurring Complicated UTI Revenue and Growth Rate (2017-2027)
6.4. Uncomplicated UTI
6.4.1. Global Uncomplicated UTI Revenue and Growth Rate (2017-2027)
6.5. Complicated UTI
6.5.1. Global Complicated UTI Revenue and Growth Rate (2017-2027)
7. Urinary Tract Infection Treatment Market, By Distribution Channel
7.1. Introduction
7.2. Global Urinary Tract Infection Treatment Revenue and Market Share by Distribution Channel (2017-2027)
7.2.1. Global Urinary Tract Infection Treatment Revenue and Revenue Share by Distribution Channel (2017-2027)
7.3. Retail Pharmacies
7.3.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)
7.4. Hospital Pharmacies
7.4.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)
7.5. e-Pharmacies
7.5.1. Global e-Pharmacies Revenue and Growth Rate (2017-2027)
8. Urinary Tract Infection Treatment Market, By Region
8.1. Introduction
8.2. Global Urinary Tract Infection Treatment Revenue and Market Share by Regions
8.2.1. Global Urinary Tract Infection Treatment Revenue by Regions (2017-2027)
8.3. North America Urinary Tract Infection Treatment by Countries
8.3.1. North America Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2027)
8.3.2. North America Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Urinary Tract Infection Treatment by Countries
8.4.1. Europe Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2027)
8.4.2. Europe Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Urinary Tract Infection Treatment by Countries
8.5.1. Asia-Pacific Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Urinary Tract Infection Treatment by Countries
8.6.1. South America Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2027)
8.6.2. South America Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Urinary Tract Infection Treatment by Countries
8.7.1. Middle East and Africa Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. F. Hoffmann-La Roche Ltd.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Novartis AG
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Roche Ltd.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Cipla Ltd.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Boehringer Ingelheim
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Johnson & Johnson
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. GlaxoSmithKline
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. AstraZeneca Plc
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Bayer AG
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Pfizer Inc.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Urinary Tract Infection Treatment Market Competition, by Manufacturer
10.1. Global Urinary Tract Infection Treatment Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Urinary Tract Infection Treatment Price By Region (2017-2017)
10.3. Top 5 Urinary Tract Infection Treatment Manufacturer Market Share
10.4. Market Competition Trend
11. Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.1. Global Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Urinary Tract Infection Treatment Market Forecast by Regions (2017-2027)
11.2.1. North America Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.1.1. United States Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.1.2. Canada Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.1.3. Mexico Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.2. Europe Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.2.1. Germany Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.2.2. France Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.2.3. UK Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.2.4. Russia Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.2.5. Italy Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.3. Asia-Pacific Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.3.1. China Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.3.2. Japan Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.3.3. Korea Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.3.4. India Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.4. South America Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.4.1. Brazil Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.4.2. Argentina Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.4.3. Columbia Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.4.4. Rest of South America Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5. Middle East and Africa Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5.3. Egypt Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5.4. Nigeria Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5.5. South Africa Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5.6. Turkey Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Urinary Tract Infection Treatment Market Forecast (2017-2027)
11.3. Urinary Tract Infection Treatment Market Forecast by Drug Type (2017-2027)
11.3.1. Urinary Tract Infection Treatment Forecast by Drug Type (2017-2027)
11.3.2. Urinary Tract Infection Treatment Market Share Forecast by Drug Type (2017-2027)
11.4. Urinary Tract Infection Treatment Market Forecast by Indication (2017-2027)
11.4.1. Urinary Tract Infection Treatment Forecast by Indication (2017-2027)
11.4.2. Urinary Tract Infection Treatment Market Share Forecast by Indication (2017-2027)
11.5. Urinary Tract Infection Treatment Market Forecast by Distribution Channel (2017-2027)
11.5.1. Urinary Tract Infection Treatment Forecast by Distribution Channel (2017-2027)
11.5.2. Urinary Tract Infection Treatment Market Share Forecast by Distribution Channel (2017-2027)
List of Tables
12. List of Tables and Figures
Figure United States Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Urinary Tract Infection Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Urinary Tract Infection Treatment Revenue and Revenue Share by Drug Type (2017-2018)
Figure Global Tetracycline Revenue and Growth Rate (2017-2018)
Figure Global Azoles and Amphotericin B Revenue and Growth Rate (2017-2018)
Figure Global Nitrofurans Revenue and Growth Rate (2017-2018)
Figure Global Quinolones Revenue and Growth Rate (2017-2018)
Figure Global Aminoglycoside antibiotics Revenue and Growth Rate (2017-2018)
Figure Global Sulphonamides Revenue and Growth Rate (2017-2018)
Figure Global Other Drug Types Revenue and Growth Rate (2017-2018)
Table Global Urinary Tract Infection Treatment Revenue and Revenue Share by Indication (2017-2018)
Figure Global Recurring Complicated UTI Revenue and Growth Rate (2017-2018)
Figure Global Uncomplicated UTI Revenue and Growth Rate (2017-2018)
Figure Global Complicated UTI Revenue and Growth Rate (2017-2018)
Table Global Urinary Tract Infection Treatment Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global e-Pharmacies Revenue and Growth Rate (2017-2018)
Table Global Urinary Tract Infection Treatment Revenue by Regions (2017-2018)
Figure North America Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure North America Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2018)
Figure North America Urinary Tract Infection Treatment by Countries (2017-2018)
Figure North America Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure United States Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Canada Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Mexico Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Europe Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Urinary Tract Infection Treatment by Countries (2017-2018)
Figure Europe Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Germany Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure France Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure UK Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Russia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Italy Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Rest of Europe Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Urinary Tract Infection Treatment by Countries (2017-2018)
Figure Asia-Pacific Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure China Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Japan Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Korea Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure India Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Southeast Asia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure South America Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2018)
Figure South America Urinary Tract Infection Treatment by Countries (2017-2018)
Figure South America Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Brazil Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Argentina Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Columbia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Rest of South America Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Urinary Tract Infection Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Urinary Tract Infection Treatment by Countries (2017-2018)
Figure Middle East and Africa Urinary Tract Infection Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Egypt Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Nigeria Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure South Africa Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Turkey Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Urinary Tract Infection Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table F. Hoffmann-La Roche Ltd. Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis AG Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Ltd. Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cipla Ltd. Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Johnson & Johnson Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca Plc Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer AG Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Urinary Tract Infection Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Urinary Tract Infection Treatment Market Share by Manufacturer
Figure Global Urinary Tract Infection Treatment Revenue and Market Share by Manufacturer
Table Global Urinary Tract Infection Treatment Price by Region (2017-2017)
Figure Top 5 Urinary Tract Infection Treatment Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Urinary Tract Infection Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Urinary Tract Infection Treatment Market Forecast by Regions (2018-2025)
Figure North America Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure United States Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Canada Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Mexico Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Europe Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Germany Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure France Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure UK Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Russia Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Italy Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Rest of Europe Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure China Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Japan Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Korea Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure India Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Southeast Asia Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure South America Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Brazil Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Argentina Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Columbia Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Rest of South America Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Egypt Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Nigeria Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure South Africa Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Turkey Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Urinary Tract Infection Treatment Market Forecast (2018-2025)
Figure Global Urinary Tract Infection Treatment Forecast by Drug Type (2018-2025)
Figure Global Urinary Tract Infection Treatment Market Share Forecast by Drug Type (2018-2025)
Figure Global Urinary Tract Infection Treatment Forecast by Drug Type (2018-2025)
Figure Global Urinary Tract Infection Treatment Forecast by Indication (2018-2025)
Figure Global Urinary Tract Infection Treatment Market Share Forecast by Indication (2018-2025)
Figure Global Urinary Tract Infection Treatment Forecast by Indication (2018-2025)
Figure Global Urinary Tract Infection Treatment Forecast by Distribution Channel (2018-2025)
Figure Global Urinary Tract Infection Treatment Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Urinary Tract Infection Treatment Forecast by Distribution Channel (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|